RWA Wealth Partners’s Avanos Medical AVNS Stock Holding History

RWA Wealth Partners’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-125	Closed	-$7K	–	264
2018 Q2	$7K	Hold	125	–	–	﹤0.01%	640
2018 Q1	$6K	Buy	+125	New	+$5.93K	﹤0.01%	475

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RWA Wealth Partners's AVNS Position: Q3 2018 in Review

RWA Wealth Partners sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 125 shares — an estimated $7K sold.

RWA Wealth Partners first reported a position in AVNS in Q1 2018 and held it in 2 quarters. The position peaked at $7K in Q2 2018. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

RWA Wealth Partners reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
RWA Wealth Partners sold 125 Avanos Medical shares in Q3 2018, an estimated $7K.
RWA Wealth Partners first reported a position in Avanos Medical in Q1 2018 and held it in 2 quarters.
RWA Wealth Partners's Avanos Medical position peaked at $7K in Q2 2018.
387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on RWA Wealth Partners's 13F filing for Q3 2018, filed 14 Nov 2018.